Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region

Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Five Hospital of the Alpine Region

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04845984

Acronym

PACAAP

Enrollment

3500

Registered

2021-04-15

Start date

2020-09-01

Completion date

2021-01-15

Last updated

2021-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Health Care Worker

Brief summary

The PACAAP study aims to report the seroprevalence of SARS-CoV-2 IgG antibodies among HCWs testing during the massive campaign screening set up in France by French ministry of Health and national authorities in four hospital of the Alpine region.

Detailed description

In France during the first wave of the pandemic, 30,230 symptomatic healthcare workers had been reported positive. Yet, the prevalence of the infection in French healthcare workers remains unknown as it mostly reflect symptomatic infections. Also, the prevalence of infection was reported being higher in male healthcare workers, and in those having patients' facing roles. However, the impact of the level of exposure to SARS-CoV-2, the use of personal protective equipment and hospital organization to prevent infection and spread remains unclear. Our study aims to report the seroprevalence of SARS-CoV-2 infection among French healthcare workers after the first wave of the pandemic. It also aims to explore the impact of the type of occupations and the level of exposure to the viruses on the seroprevalence of infection.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Hospital staff employee * Employed in one of the participating centers * Volunteers to perform SARS-CoV-2 serology * Permanent or occasional staff (temporary workers, short contracts) * Caregivers or not (medical, paramedical, administrative, technical staff)

Exclusion criteria

* Staff who are not working at a participating center while participating in the study * Person under guardianship or curatorship * Opposition to data collection

Design outcomes

Primary

Measure	Time frame	Description
SARS-CoV-2 prevalency among hospital health care professionals	Day 1	Number of Health Care Worker with an antibody test (IgG) positive for SARS-CoV2

Countries

France

Outcome results